166 related articles for article (PubMed ID: 32458409)
21. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
22. Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.
Norman R; Kemmler G; Viney R; Pickard AS; Gamper E; Holzner B; Nerich V; King M
Value Health; 2016 Dec; 19(8):1033-1038. PubMed ID: 27987630
[TBL] [Abstract][Full Text] [Related]
23. The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L.
Gamper EM; Cottone F; Sommer K; Norman R; King M; Breccia M; Caocci G; Patriarca A; Palumbo GA; Stauder R; Niscola P; Platzbecker U; Caers J; Vignetti M; Efficace F
J Clin Epidemiol; 2021 Sep; 137():31-44. PubMed ID: 33753228
[TBL] [Abstract][Full Text] [Related]
24. Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.
Norman R; Viney R; Aaronson NK; Brazier JE; Cella D; Costa DS; Fayers PM; Kemmler G; Peacock S; Pickard AS; Rowen D; Street DJ; Velikova G; Young TA; King MT
Qual Life Res; 2016 Mar; 25(3):637-49. PubMed ID: 26342928
[TBL] [Abstract][Full Text] [Related]
25. Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score.
Klapproth CP; Fischer F; Rose M; Karsten MM
J Clin Epidemiol; 2022 Dec; 152():101-109. PubMed ID: 36162712
[TBL] [Abstract][Full Text] [Related]
26. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Pilz MJ; Seyringer S; Hallsson LR; Bottomley A; Jansen F; King MT; Norman R; Rutten MJ; Leeuw IMV; Siersema PD; Gamper EM
Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38483665
[TBL] [Abstract][Full Text] [Related]
27. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis.
Kim H; Cook G; Goodall S; Liew D
Pharmacoecon Open; 2021 Sep; 5(3):459-467. PubMed ID: 33891268
[TBL] [Abstract][Full Text] [Related]
28. Health utility assessments in individuals undergoing diagnostic and surveillance colonoscopy: improved discrimination with a cancer-specific scale.
Bulamu NB; Chen G; McGrane E; Cock C; Young GP; Symonds EL
Cancer Causes Control; 2024 Feb; 35(2):347-357. PubMed ID: 37747615
[TBL] [Abstract][Full Text] [Related]
29. Normative data for the EORTC QLQ-C30 from the Austrian general population.
Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B;
Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854
[TBL] [Abstract][Full Text] [Related]
30. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
[TBL] [Abstract][Full Text] [Related]
31. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
[TBL] [Abstract][Full Text] [Related]
32. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
33. Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.
Bulamu NB; Chen G; Ratcliffe J; Schloite A; Bright T; Watson DI
World J Surg; 2019 Jun; 43(6):1554-1562. PubMed ID: 30719557
[TBL] [Abstract][Full Text] [Related]
34. Development of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal Caregiving.
Baji P; Farkas M; Golicki D; Prevolnik Rupel V; Hoefman R; Brouwer WBF; van Exel J; Zrubka Z; Gulácsi L; Péntek M
Pharmacoeconomics; 2020 Jun; 38(6):633-643. PubMed ID: 32201921
[TBL] [Abstract][Full Text] [Related]
35. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
36. The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set.
King MT; Norman R; Mercieca-Bebber R; Costa DSJ; McTaggart-Cowan H; Peacock S; Janda M; Müller F; Viney R; Pickard AS; Cella D;
Value Health; 2021 Jun; 24(6):862-873. PubMed ID: 34119085
[TBL] [Abstract][Full Text] [Related]
37. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.
Lloyd AJ; Kerr C; Penton J; Knerer G
Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802
[TBL] [Abstract][Full Text] [Related]
38. Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.
Ratcliffe J; Flynn T; Terlich F; Stevens K; Brazier J; Sawyer M
Pharmacoeconomics; 2012 Aug; 30(8):713-27. PubMed ID: 22788261
[TBL] [Abstract][Full Text] [Related]
39. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
King MT; Costa DSJ; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
Qual Life Res; 2016 Oct; 25(10):2683. PubMed ID: 27060088
[No Abstract] [Full Text] [Related]
40. Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT).
Gamper EM; Petersen MA; Aaronson N; Costantini A; Giesinger JM; Holzner B; Kemmler G; Oberguggenberger A; Singer S; Young T; Groenvold M;
Health Qual Life Outcomes; 2016 May; 14():72. PubMed ID: 27150974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
